Last 12 months
Inside the activity.
0 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 1 |
| Jan 2026 | 0 | 7 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 1 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| July 10, 2026 Filed Jul 10, 2026 22:54 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 200,000 | $6.24 | $1,248,000.00 |
DisclosureSEC source: 0001665124-26-000013 · form4-07102026_100732.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 936,410 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $5.99 to $6.52 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Stalfort John A IIIDirector
|
GrantStock Option (right to buy) · Derivative | 42,671 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0001709418-26-000002 · form4-06022026_040616.xml · derivative · entry 3 Stalfort John A III · CIK 0001709418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 Underlying: Common Stock · 42,671 shares Expires 2036-06-01 F3 · derivative.exercise_date: The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Stalfort John A IIIDirector
|
GrantCommon Stock | 21,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001709418-26-000002 · form4-06022026_040616.xml · nonDerivative · entry 1 Stalfort John A III · CIK 0001709418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,176,559 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Donenberg Phillip B.Director
|
GrantStock Option (right to buy) · Derivative | 42,671 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0001238120-26-000008 · form4-06022026_040614.xml · derivative · entry 2 Donenberg Phillip B. · CIK 0001238120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 Underlying: Common Stock · 42,671 shares Expires 2036-06-01 F2 · derivative.exercise_date: The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Donenberg Phillip B.Director
|
GrantCommon Stock | 21,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001238120-26-000008 · form4-06022026_040614.xml · nonDerivative · entry 1 Donenberg Phillip B. · CIK 0001238120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 241,289 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Long Alison SDirector
|
GrantStock Option (right to buy) · Derivative | 42,671 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0001891712-26-000002 · form4-06022026_040612.xml · derivative · entry 2 Long Alison S · CIK 0001891712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 Underlying: Common Stock · 42,671 shares Expires 2036-06-01 F2 · derivative.exercise_date: The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Long Alison SDirector
|
GrantCommon Stock | 21,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001891712-26-000002 · form4-06022026_040612.xml · nonDerivative · entry 1 Long Alison S · CIK 0001891712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,178 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Sepp-Lorenzino LauraDirector
|
GrantStock Option (right to buy) · Derivative | 42,671 | $0.00 Strike: $5.97 | $0.00 |
DisclosureSEC source: 0001777421-26-000005 · form4-06022026_040610.xml · derivative · entry 2 Sepp-Lorenzino Laura · CIK 0001777421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,671 Underlying: Common Stock · 42,671 shares Expires 2036-06-01 F2 · derivative.exercise_date: The shares vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 01, 2026 Filed Jun 2, 2026 20:30 UTC |
Sepp-Lorenzino LauraDirector
|
GrantCommon Stock | 21,335 | $0.00 | $0.00 |
DisclosureSEC source: 0001777421-26-000005 · form4-06022026_040610.xml · nonDerivative · entry 1 Sepp-Lorenzino Laura · CIK 0001777421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,178 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 1, 2027 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:33 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 19,021 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001665124-26-000011 · form4-04132026_080454.xml · derivative · entry 3 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 455,920 Underlying: Common Stock · 19,021 shares Expires 2034-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:33 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 200,000 | $4.46 | $892,000.00 |
DisclosureSEC source: 0001665124-26-000011 · form4-04132026_080454.xml · nonDerivative · entry 2 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,136,410 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.335 to $4.625 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| April 10, 2026 Filed Apr 13, 2026 20:33 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 19,021 | $1.71 | $32,525.91 |
DisclosureSEC source: 0001665124-26-000011 · form4-04132026_080454.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,336,410 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 04, 2026 Filed Feb 6, 2026 21:30 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 1,655 | $4.52 | $7,480.60 |
DisclosureSEC source: 0001793412-26-000012 · form4-02062026_040223.xml · nonDerivative · entry 1 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,442,131 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:05 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 26,918 | $4.61 | $124,091.98 |
DisclosureSEC source: 0001665124-26-000008 · form4-01272026_040105.xml · nonDerivative · entry 2 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,317,389 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:05 UTC |
Nolan Sean P.Director · Chief Executive Officer
|
SaleCommon Stock | 41,312 | $4.61 | $190,448.32 |
DisclosureSEC source: 0001569926-26-000008 · form4-01272026_040103.xml · nonDerivative · entry 2 Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,908,257 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive. Read SEC document |
| January 26, 2026 Filed Jan 27, 2026 21:05 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 23,849 | $4.61 | $109,943.89 |
DisclosureSEC source: 0001793412-26-000008 · form4-01272026_040101.xml · nonDerivative · entry 2 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,443,786 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F3 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.505 to $4.715 inclusive. Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:05 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 89,132 | $4.75 | $423,377.00 |
DisclosureSEC source: 0001665124-26-000008 · form4-01272026_040105.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,344,307 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:05 UTC |
Nolan Sean P.Director · Chief Executive Officer
|
SaleCommon Stock | 136,789 | $4.75 | $649,747.75 |
DisclosureSEC source: 0001569926-26-000008 · form4-01272026_040103.xml · nonDerivative · entry 1 Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,949,569 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| January 23, 2026 Filed Jan 27, 2026 21:05 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 78,968 | $4.75 | $375,098.00 |
DisclosureSEC source: 0001793412-26-000008 · form4-01272026_040101.xml · nonDerivative · entry 1 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,467,635 F1 · shares: The Reporting Person is selling the securities set forth herein pursuant to a mandatory sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.635 to $4.99 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (2) and (3). Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
GrantEmployee Stock Option (right to buy) · Derivative | 231,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001793412-26-000002 · form4-01142026_040105.xml · derivative · entry 2 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 231,000 Underlying: Common Stock · 231,000 shares Expires 2036-01-12 F2 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
GrantCommon Stock | 359,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001793412-26-000002 · form4-01142026_040105.xml · nonDerivative · entry 1 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,546,603 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nolan Sean P.Director · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 648,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001569926-26-000002 · form4-01142026_040103.xml · derivative · entry 3 Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 648,000 Underlying: Common Stock · 648,000 shares Expires 2036-01-12 F3 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nolan Sean P.Director · Chief Executive Officer
|
GrantCommon Stock | 1,008,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001569926-26-000002 · form4-01142026_040103.xml · nonDerivative · entry 1 Nolan Sean P. · CIK 0001569926 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,086,358 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
GrantEmployee Stock Option (right to buy) · Derivative | 274,000 | $0.00 Strike: $4.86 | $0.00 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · derivative · entry 7 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 274,000 Underlying: Common Stock · 274,000 shares Expires 2036-01-12 F6 · derivative.exercise_date: 25% of the total number of shares underlying the option shall vest and become exercisable on January 12, 2027 and the remainder shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 88,676 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · derivative · entry 6 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 474,941 Underlying: Common Stock · 88,676 shares Expires 2034-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 111,324 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · derivative · entry 5 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 111,359 Underlying: Common Stock · 111,324 shares Expires 2033-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The shares underlying the option vested or shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
GrantCommon Stock | 427,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · nonDerivative · entry 4 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,433,439 F3 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest in four equal annual installments beginning on January 12, 2027, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 200,000 | $4.71 | $942,000.00 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · nonDerivative · entry 3 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,006,439 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.565 to $4.92 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 88,676 | $1.71 | $151,635.96 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · nonDerivative · entry 2 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 12, 2026 Filed Jan 14, 2026 21:45 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 111,324 | $0.70 | $77,804.34 |
DisclosureSEC source: 0001665124-26-000002 · form4-01142026_040101.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,117,763 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 260,047 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · derivative · entry 8 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 563,617 Underlying: Common Stock · 260,047 shares Expires 2034-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 260,047 | $4.51 | $1,172,811.97 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · nonDerivative · entry 5 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006,439 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.42 to $4.63 inclusive. Read SEC document |
| December 01, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 260,047 | $1.71 | $444,680.37 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · nonDerivative · entry 4 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,266,486 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 39,953 | $0.00 Strike: $1.71 | $0.00 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · derivative · entry 7 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 823,664 Underlying: Common Stock · 39,953 shares Expires 2034-01-02 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: 25% of the total number of shares underlying the option vested and became exercisable on January 2, 2025 and the remainder vested or shall vest and become exercisable in 36 equal monthly installments thereafter, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 70,172 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · derivative · entry 6 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 222,683 Underlying: Common Stock · 70,172 shares Expires 2033-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying the option vested or shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 110,125 | $4.75 | $523,093.75 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · nonDerivative · entry 3 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,006,439 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.7248 to $4.8348 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnotes (1) and (2). Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 39,953 | $1.71 | $68,319.63 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · nonDerivative · entry 2 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,116,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| November 28, 2025 Filed Dec 2, 2025 01:58 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 70,172 | $0.70 | $49,043.21 |
DisclosureSEC source: 0001665124-25-000003 · form4-12022025_011240.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,076,611 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:15 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionEmployee Stock Option (right to buy) · Derivative | 41,150 | $0.00 Strike: $0.70 | $0.00 |
DisclosureSEC source: 0001415889-25-024369 · form4-09122025_040917.xml · derivative · entry 3 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 292,855 Underlying: Common Stock · 41,150 shares Expires 2033-12-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: The shares underlying the option vested or shall vest and become exercisable in three equal annual installments commencing on December 31, 2024, subject to the Reporting Person's continuous service through each applicable vesting date. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:15 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 200,000 | $3.23 | $646,000.00 |
DisclosureSEC source: 0001415889-25-024369 · form4-09122025_040917.xml · nonDerivative · entry 2 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,006,439 F1 · kind: This transaction was made pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2025. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.165 to $3.31 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| September 10, 2025 Filed Sep 12, 2025 20:15 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
Exercise / conversionCommon Stock | 41,150 | $0.70 | $28,759.74 |
DisclosureSEC source: 0001415889-25-024369 · form4-09122025_040917.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 1,206,439 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 20:15 UTC |
Nagendran SukumarDirector · President and Head of R&D
|
SaleCommon Stock | 57,054 | $2.85 | $162,603.90 |
DisclosureSEC source: 0001415889-25-022750 · form4-08222025_040806.xml · nonDerivative · entry 1 Nagendran Sukumar · CIK 0001665124 · Director · President and Head of R&D 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,165,289 F1 · shares: Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.841 to $2.865 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| August 21, 2025 Filed Aug 22, 2025 20:15 UTC |
Alam KamranCHIEF FINANCIAL OFFICER
|
SaleCommon Stock | 54,491 | $2.85 | $155,299.35 |
DisclosureSEC source: 0001415889-25-022749 · form4-08222025_040804.xml · nonDerivative · entry 1 Alam Kamran · CIK 0001793412 · CHIEF FINANCIAL OFFICER 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,187,603 F1 · shares: Represents shares sold pursuant to a sell-to-cover arrangement for the purpose of satisfying income tax liabilities incurred upon vesting of restricted stock unit awards only. F2 · price: The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.841 to $2.865 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Stalfort John A IIIDirector
|
GrantStock Option (right to buy) · Derivative | 113,246 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001415889-25-015574 · form4-06042025_040609.xml · derivative · entry 3 Stalfort John A III · CIK 0001709418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,246 Underlying: Common Stock · 113,246 shares Expires 2035-06-02 F3 · derivative.exercise_date: The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Stalfort John A IIIDirector
|
GrantCommon Stock | 56,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015574 · form4-06042025_040609.xml · nonDerivative · entry 1 Stalfort John A III · CIK 0001709418 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,155,224 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Donenberg Phillip B.Director
|
GrantStock Option (right to buy) · Derivative | 113,246 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001415889-25-015573 · form4-06042025_040607.xml · derivative · entry 2 Donenberg Phillip B. · CIK 0001238120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,246 Underlying: Common Stock · 113,246 shares Expires 2035-06-02 F2 · derivative.exercise_date: The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Donenberg Phillip B.Director
|
GrantCommon Stock | 56,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015573 · form4-06042025_040607.xml · nonDerivative · entry 1 Donenberg Phillip B. · CIK 0001238120 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 219,954 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Long Alison SDirector
|
GrantStock Option (right to buy) · Derivative | 113,246 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001415889-25-015572 · form4-06042025_040604.xml · derivative · entry 2 Long Alison S · CIK 0001891712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,246 Underlying: Common Stock · 113,246 shares Expires 2035-06-02 F2 · derivative.exercise_date: The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Long Alison SDirector
|
GrantCommon Stock | 56,623 | $0.00 | $0.00 |
DisclosureSEC source: 0001415889-25-015572 · form4-06042025_040604.xml · nonDerivative · entry 1 Long Alison S · CIK 0001891712 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,843 F1 · shares: Represents a restricted stock unit ("RSU") award. The RSUs will vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:15 UTC |
Sepp-Lorenzino LauraDirector
|
GrantStock Option (right to buy) · Derivative | 113,246 | $0.00 Strike: $2.79 | $0.00 |
DisclosureSEC source: 0001415889-25-015571 · form4-06042025_040601.xml · derivative · entry 2 Sepp-Lorenzino Laura · CIK 0001777421 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 113,246 Underlying: Common Stock · 113,246 shares Expires 2035-06-02 F2 · derivative.exercise_date: The shares vest on the earlier of June 2, 2026 or the next annual stockholders meeting, subject to the Reporting Person's continued service as a director through the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.